Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients

Jeppesen, P. B.; Sanguinetti, E. L.; Buchman, A.; Howard, L.; Scolapio, J. S.; Ziegler, T. R.; Gregory, J.; Tappenden, K. A.; Holst, J.; Mortensen, P. B.
September 2005
Gut;Sep2005, Vol. 54 Issue 9, p1224
Academic Journal
Background and aims: Glucagon-like peptide 2 (GLP-2) may improve intestinal absorption in short bowel syndrome (SBS) patients with an end jejunostomy. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant GLP-2 analogue, prolongs the intestinotrophic properties of GLP-2 in animal models. The safely and effect of teduglutide were investigated in SBS patients with and without a colon in continuity. Methods: Teduglutide was given subcutaneously for 21 days once or twice daily to 16 SBS patients in the per protocol investigational group, 10 with end jejunostomy (doses of 0.03 (n = 2), 0.10 (n =5), or 0.15 (n =3) mg/kg/day), one with <50% colon in continuity (dose 0.03 mg/kg/day), and five with ⩾50% colon in continuity (dose 0.10 mg/kg/day). Nutrient balance studies, D-xylose tests, and intestinal mucosa biopsies were performed at baseline, on the last three days of treatment, and after three weeks of follow up. Pre-study fasting native GLP-2 levels were determined for the five patients with ⩾50% colon in continuity. Results: Pooled across groups and compared with baseline, teduglutide increased absolute (+743 (477) g/day; p<0.001) and relative (+22 (16)%; p<0.001) wet weight absorption, urine weight (+555 (485) g/day; p<0.001), and urine sodium excretion (+53 (40) mmol/day; p<0.001). Teduglutide decreased faecal wet weight (-711 (734) g/day; p = 0.001) and faecal energy excretion (-808 (1453) kJ/day (-193 (347) kcal/day); p = 0.040). In SBS patients with end jejunostomy, teduglutide significantly increased villus height (+38 (45)%; p =0.030), crypt depth (+22 (18)%; p = 0.010), and mitotic index (+115 (108)%; p = 0.010). Crypt depth and mitotic index did not change in colonic biopsies from SBS patients with colon in continuity. The most common side effects were enlargement of the stoma nipple and mild lower leg oedema. The improvements in intestinal absorption and decreases in faecal excretion noted after treatment had reversed after the drug free follow up period. A controlled study with a more robust design is ongoing in order to determine the optimal dosage of teduglutide for SBS patients to achieve the maximal effect and utility of this drug in clinical practice. Conclusion: Teduglutide, at three dose levels for 21 days, was safe and well tolerated, intestinotrophic, and significantly increased intestinal wet weight absorption in SBS patients with an end jejunostomy or a colon in continuity.


Related Articles

  • Impaired Detoxication of Hydrogen Sulfide in Ulcerative Colitis? R. Picton; M. Eggo; M. Langman // Digestive Diseases & Sciences;Feb2007, Vol. 52 Issue 2, p373 

    Abstract??Impaired butyrate oxidation and raised counts of sulfate-reducing bacteria in the colon of patients with ulcerative colitis (UC) indicate that the disease may be induced or aggravated by hydrogen sulfide toxicity. We aimed to examine enzymatic removal of H2S in erythrocytes and colonic...

  • GLUCAGON. Schnell, Zoanne Burgess; Van Leeuwen, Anne M.; Kranpitz, Todd R. // Davis's Comprehensive Handbook of Laboratory & Diagnostic Tests ;Jan2003, p534 

    Presents a laboratory and diagnostic guide for testing glucagon, a hormone secreted by the alpha cells of the islets of Langerhans in the pancreas in response to hypoglycemia. Clinical indications of glucagon; Outcome of the increased or decreased level of glucagon; Factors which may interfere...

  • Antimicrobial peptides in innate immunity of the human intestine. Otte, Jan-Michel; Kiehne, Karlheinz; Herzig, Karl-Heinz // Journal of Gastroenterology;2003, Vol. 38 Issue 8, p717 

    The intestinal mucosa has to withstand exposure to a variety of substances, challenges in pH, temperature, and osmolarity; and, finally, bacterial products which might induce local and systemic inflammatory responses. The mucosal integrity is conserved by a defense system which consisting of...

  • Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus. PohI, H; Rösch, T; Vieth, M; Koch, M; Becker, V; Anders, M; Khalifa, A C; Meining, A // Gut;Dec2008, Vol. 57 Issue 12, p1648 

    Objective: The biggest challenge in endoscopic surveil lance of Barrett's oesophagus is better detection of neoplasia in mucosa of normal macroscopic appearanc~ We evaluated in vivo miniprobe confocal laser microsco~ (CLM) for the detection of invisible Barrett's neoplasia. Design: Prospective...

  • The innervation of human bowel mucosa and its alterations in Hirschsprung's disease using a whole-mount preparation technique. Nemeth, L.; Puri, P. // Pediatric Surgery International;May2000, Vol. 16 Issue 4, p277 

    The innervation of the human bowel wall and its structural and functional changes in Hirschsprung's disease (HD) are well-recognised. The luminal surface of the bowel acts as a multifunctional barrier, and modifications in its physiochemical properties can result in serious complications such as...

  • One Patient, Two Lymphomas. Tang, Zuoqin; Jing, Wen; Lindeman, Neal; Harris, Nancy Lee; Ferry, Judith A. // Archives of Pathology & Laboratory Medicine;Sep2004, Vol. 128 Issue 9, p1035 

    We report the case of a 73-year-old man who presented with a 2- to 3-month history of epigastric discomfort and guaiac-positive stool. An upper gastrointestinal endoscopy revealed a diffuse erythematous nodular mucosa and submucosal thickening in the stomach. Diffuse mucosal nodularity was also...

  • A 54-Year-Old Liver Transplant Recipient With Diffuse Thickening of the Sigmoid Colon. Weinrach, David M.; Wang, Kim L.; Cisler, Jason J.; Diaz, Leslie K. // Archives of Pathology & Laboratory Medicine;Oct2004, Vol. 128 Issue 10, pe133 

    This article focuses on a case study related to thickening of the sigmoid colon. A 54-year-old man presented with a several-week history of fever, diarrhea, and jaundice. His past medical history was significant for a liver transplant 1 year earlier for hepatocellular carcinoma secondary to...

  • Biopsy interpretation of the uterine cervix and corpus (Biopsy interpretation series). Clarke, B. A. // Journal of Clinical Pathology;Apr2010, Vol. 63 Issue 4, p377 

    It is claimed that things are always bigger in the Lone Star state; and that is partially true of the latest offering in the Biopsy Interpretation Series. While some books leave jobbing pathologists with a sense of 'big hat, no cattle'. The MD Anderson trio of Malpica, Deavers and Euscher are...

  • Q: Is a biopsy painful?  // Mayo Clinic Guide to Women's Cancers;2005, p379 

    This article describes the pain caused by having an endometrial biopsy. You may feel some pain during an endometrial biopsy, something similar to menstrual cramps. Some women may also have cramps and vaginal bleeding for a few days after a biopsy. To reduce your discomfort, your doctor may...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics